Compliance Rate

Compliance Rate 62.5%
Compliant submissions 5
Incompliant submissions 3
Total trials 8

My Organizations' Clinical Trials

Showing 375 of 1349 entries
View as:

Behavioral and Neural Characteristics of Adaptive Speech Motor Control

Phase: N/A Priority: Normal
NCT ID: NCT06164717 Org: User:
Start: 01/01/23 End: 12/31/27 Due: 12/31/28

Comparing State Payer Strategies to Prevent Unsafe Opioid Prescribing

Phase: N/A Priority: Normal
NCT ID: NCT03932799 Org: User:
Start: 08/06/19 End: 06/30/22 Due: 06/30/23

Mobile Phone Messaging to Improve Women's and Children's Health (Mobile WACh) in Kenya

Phase: N/A Priority: Normal
NCT ID: NCT01894126 Org: User:
Start: 07/31/13 End: - Due: -

Shear Wave Ultrasound Elastography in Noninvasive Diagnosis of Thyroid Nodules

Phase: N/A Priority: Normal
NCT ID: NCT01757834 Org: User:
Start: 11/30/12 End: 08/31/15 Due: 08/31/16

ITT4 Intratesticular Hormonal Milieu in Man (ITT4)

Phase: N/A Priority: Normal
NCT ID: NCT01215292 Org: User:
Start: 01/31/11 End: 03/31/12 Due: 03/31/13

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01355393 Org: User:
Start: 07/31/11 End: - Due: -

CBT Texts for PTSD & Hazardous Drinking (Project Better)

Phase: N/A Priority: Normal
NCT ID: NCT05372042 Org: User:
Start: 10/31/22 End: 04/25/24 Due: 04/25/25

Real-world Experiences of Alcohol and Cognitions Over Time

Phase: N/A Priority: Normal
NCT ID: NCT06579521 Org: User:
Start: 08/31/24 End: 08/31/25 Due: 08/31/26

Brief Intervention in Primary Care for Problem Drug Use and Abuse

Phase: N/A Priority: Normal
NCT ID: NCT00877331 Org: User:
Start: 04/30/09 End: 09/30/14 Due: 09/30/15

Hormone and Information Processing Study

Phase: N/A Priority: Normal
NCT ID: NCT00539305 Org: User:
Start: 07/31/09 End: 05/31/12 Due: 05/31/13

RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia

Phase: N/A Priority: Normal
NCT ID: NCT03323801 Org: User:
Start: 07/25/17 End: 05/31/19 Due: 05/31/20

Socially Isolated Older Adults Living With Dementia

Phase: N/A Priority: Normal
NCT ID: NCT03666624 Org: User:
Start: 08/06/20 End: 12/30/20 Due: 12/30/21

Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major

Phase: N/A Priority: Normal
NCT ID: NCT01206075 Org: User:
Start: 10/31/10 End: 12/31/14 Due: 12/31/15

Comparison of the Efficacy and Mechanisms for MBCT and CT for Multiple Sclerosis (MS) Chronic Pain

Phase: N/A Priority: Normal
NCT ID: NCT02012439 Org: User:
Start: 10/31/13 End: 12/31/16 Due: 12/31/17

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

Phase: N/A Priority: Normal
NCT ID: NCT00465205 Org: User:
Start: 01/31/05 End: 12/31/07 Due: 12/31/08

Cognitive Testing for the Pain Quality Assessment Scale (PQAS)

Phase: N/A Priority: Normal
NCT ID: NCT00715598 Org: User:
Start: 06/30/08 End: 08/31/10 Due: 08/31/11

Innovations in Dementia Empowerment and Action

Phase: N/A Priority: Normal
NCT ID: NCT03550131 Org: User:
Start: 12/05/18 End: 05/16/23 Due: 05/16/24

Comparison of Transcutaneous and Epidural Spinal Stimulation for Improving Function

Phase: N/A Priority: Normal
NCT ID: NCT04043715 Org: User:
Start: 08/01/19 End: 10/31/22 Due: 10/31/23

Training LHDs to Disseminate Evidence-Based Interventions to Small Worksites

Phase: N/A Priority: Normal
NCT ID: NCT03930420 Org: User:
Start: 10/01/20 End: 03/31/24 Due: 03/31/25

Project OOPEN: Opioid Overdose Prevention, Education and Intervention

Phase: N/A Priority: Normal
NCT ID: NCT01788306 Org: User:
Start: 01/31/13 End: 10/31/18 Due: 10/31/19

Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04156828 Org: User:
Start: 03/31/20 End: 06/08/23 Due: 06/08/24

Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI)

Phase: N/A Priority: Normal
NCT ID: NCT00947999 Org: User:
Start: 07/31/09 End: 10/31/11 Due: 10/31/12

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03991884 Org: User:
Start: 09/24/19 End: 06/28/23 Due: 06/28/24

Islamic Trauma Healing: Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT03761732 Org: User:
Start: 10/15/18 End: 02/06/19 Due: 02/06/20

Pain Control After Trauma

Phase: N/A Priority: Normal
NCT ID: NCT00739076 Org: User:
Start: 08/31/07 End: 12/31/14 Due: 12/31/15